Significant Increase in Antibody Titers after the 3rd Booster Dose of the Pfizer–BioNTech mRNA COVID-19 Vaccine in Healthcare Workers in Greece

The aim of our study was to assess the immunogenicity of the third dose of the BNT162b2 mRNA COVID-19 vaccine (Comirnaty) in a cohort of 129 health-care workers in Greece whose anti-S1 RBD IgG titers were monitored over the course of nine months. Titers were measured for each participant just before...

Descripción completa

Detalles Bibliográficos
Autores principales: Kontopoulou, Konstantina, Nakas, Christos T., Papazisis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228774/
https://www.ncbi.nlm.nih.gov/pubmed/35746484
http://dx.doi.org/10.3390/vaccines10060876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228774/
https://www.ncbi.nlm.nih.gov/pubmed/35746484
http://dx.doi.org/10.3390/vaccines10060876

Ejemplares similares